The Senate Judiciary Committee voted Thursday (June 14) 16-5 to advance the highly watched Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act without amendments to the Senate floor, but the path to a floor vote on the bill remains unclear. Senate Republicans unveiled three amendments to the bill Wednesday (June 13) night, all of which the generic drug lobby opposed. None of the amendments were ultimately voted on by the committee. Sen. John Cornyn (R-TX) withdrew his amendment,...